StocksMerck & Co.MRK

MRK

Merck & Co.

87.54 -0.93 (-1.05%)
Cours différés par le NASDAQ, en USD Marché fermé
Investir
V
87.54
A
87.72
Publication épinglée
Cancer-Med
Merck is in advanced talks to buy Seagen in a nearly $40 billion deal 🤝 🔸 Drugmaker $MRK (Merck & Co.) is reportedly in advanced talks to buy cancer-focused biotech company $SGEN (Seagen Inc) in a deal worth roughly $40 billion or more. The companies would be discussing a price above $200 a share... Afficher plus Traduction